Regulatory intelligence is the work of knowing what regulators expect and noticing when that changes. For a company working across several markets, the volume is the problem: new guidance, revised guidance, consultations, warning letters, inspection trends and meeting minutes, in several languages, every week.
AI is well suited to part of this work and badly suited to another part. Knowing which is which matters.
What AI does well
Monitoring and first-pass triage. Watching agency websites and publications, identifying what is new, summarising it, and sorting it by topic and relevance to your products. That is high-volume reading where speed matters and where a missed item has a cost. AI can also compare a new draft against the previous version and highlight what changed, which saves real time on long documents.
What it does badly
Interpretation. Deciding what a change means for your products, your filings and your procedures requires knowledge of your portfolio, your commitments and the history of your conversations with the agency. It also requires judgement about how a regulator is likely to apply a new expectation in practice, which is rarely in the text.
A summary that says a guidance has changed is useful. A summary that says the change does not affect you, produced without that context, is dangerous because it sounds authoritative.
Accuracy you can check
Every summary should link to the source and quote the passage it relies on. Regulatory text is precise; a summary that turns should into must, or drops a scope limitation, changes the meaning. Reviewers should be able to check a claim against the source in seconds.
Be especially careful with status. A consultation draft is not guidance in force, and an AI summary can easily blur the two. We have seen this ourselves with the draft EU GMP Annex 22, which is still a draft and is regularly described elsewhere as if it were final.
Connecting it to action
Intelligence is only useful if it reaches the people who need to act. Route relevant items to owners, record the assessment, and link any resulting change to change control or a regulatory plan. Without that, you get a well-organised feed that nobody acts on.
Language and regional nuance
Much regulatory content is published first, or only, in the local language. AI translation and summarisation can make it accessible quickly, which is a real gain for companies without local teams. But translation of regulatory text has its own risks: legal terms with no exact equivalent, and wording that carries a specific meaning in that jurisdiction.
Use AI to decide what is worth reading, and have a person who reads the language check anything you intend to act on.
A sensible setup
Let AI monitor, summarise and sort. Have people assess impact and decide what to do. Keep the source one click away. Our RIM implementation work covers how regulatory information flows into decisions, and our AI in GxP page the wider picture of where AI fits.
Where to go next
Explore GxP Copilot for AI-native validation, TraceDraft for source-traceable clinical documentation, or book a demo to see either on your own data.